CASQ1 and transient myeloproliferative syndrome: Clinical, histological, genetic, and functional data supported the finding that CASQ1 mutations significantly impair its polymerization and depolymerization and result in aggregation of STIM1, thus providing a pathological link between STIM1- and CASQ1-related TAM (Bohm et al. 2018).